Willow Rosenberg

Willow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG Committee

Retrieved on: 
Tuesday, July 20, 2021

Early research indicates that CBN may be effective as a sleep aid or sedative, in addition to other potential health benefits.

Key Points: 
  • Early research indicates that CBN may be effective as a sleep aid or sedative, in addition to other potential health benefits.
  • As Willow's team and operations grow, Willow continues to invest in its industry-leading sustainability management capabilities.
  • The ESG committee is comprised of cross-functional representatives and meets quarterly to ensure consistent progress.
  • ESG priorities for Willow in 2021 and 2022 include ESG strategy development, data management on identified safety, environmental, and social KPIs, target-setting, and internal and external stakeholder engagement.

Willow® Launches New Sizing Inserts To Reach More Moms

Retrieved on: 
Wednesday, June 2, 2021

The average flange size most new moms need ranges between 21- 27mm1, which Willow previously accommodated with its flange offerings.

Key Points: 
  • The average flange size most new moms need ranges between 21- 27mm1, which Willow previously accommodated with its flange offerings.
  • "We've listened to pumping moms who have been asking for Willow to accommodate smaller nipple sizes," said Willow Chief Marketing Officer, Sarah O'Leary.
  • "Our expanded range of sizing inserts will allow more moms to pump with a sizing product specifically designed to work optimally with Willow's unique continuous latch technology.
  • Through its life-changing technology, Willow helps moms better balance modern motherhood, allowing them to pursue their passions and purpose.

Willow Biosciences Announces Participation In Synbiobeta Panel Discussion

Retrieved on: 
Tuesday, May 25, 2021

They provide their community members with personal and professional development support, as well as valuable opportunities for partnership, collaboration, networking, and education.

Key Points: 
  • They provide their community members with personal and professional development support, as well as valuable opportunities for partnership, collaboration, networking, and education.
  • Willow is a Canadian biotechnology company that develops and produces high-purity, plant derived ingredients for consumer care, food and beverage, and pharmaceutical products.
  • Willow's manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers.
  • This news release may include forward-looking statements including opinions, assumptions, estimates and the Company's assessment of future plans and operations.

Kevin Danehy Named CEO of North America at Willow

Retrieved on: 
Wednesday, April 28, 2021

In my role at Brookfield, I had the opportunity to work with a number of different technology businesses but I see Willow as particularly unique in this space.

Key Points: 
  • In my role at Brookfield, I had the opportunity to work with a number of different technology businesses but I see Willow as particularly unique in this space.
  • Willow is placed at the centre of a technology shift for the built world and will fundamentally transform the future of real assets.
  • "\nJoshua Ridley, Global CEO said "Kevin brings a wealth of experience in the North American market and shares our vision to digitize the built world.
  • Willow has a strong reputation for both vision and execution, and Kevin possesses both in spades.

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

Retrieved on: 
Wednesday, March 31, 2021

VANCOUVER,BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc.("Willow" or the "Company") (TSX:WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG").

Key Points: 
  • VANCOUVER,BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc.("Willow" or the "Company") (TSX:WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG").
  • "We are very pleased with the yield and quality of our first commercial scale fermentation run of CBG," said Trevor Peters, Willow's President and Chief Executive Officer.
  • We are now starting the next phase of Willow's lifecycle, which will involve supplying commercial quantities of cannabinoids to customers and recognizing revenue therefrom."
  • Production from our first commercial fermentation run is earmarked for sale to prospective customers and the Company is in the process of finalizing agreements with multiple parties.

Willow Gears Up for Massive Growth In 2021 with Three Strategic Hires

Retrieved on: 
Wednesday, February 3, 2021

"Willow has grown significantly year-over-year, and we're thrilled to push our brand even further in 2021 with the introduction of five new offerings.

Key Points: 
  • "Willow has grown significantly year-over-year, and we're thrilled to push our brand even further in 2021 with the introduction of five new offerings.
  • As CPO, Judkins brings his innovation, design and hardware + software development expertise to help expand Willow's portfolio of product offerings.
  • O'Leary's role as CMO is focused on driving growth for Willow, as the company evolves from an ecommerce innovator to an omnichannel brand.
  • Jim joined Willow from GoDaddy, where he led Finance Transformation as GoDaddy helped over 20 million small businesses stay open in 2020.

Willow® Partners with The Motherly Shop to Expand Its DTC Offerings

Retrieved on: 
Tuesday, November 17, 2020

"Willow continues on a path of growth by adding The Motherly Shop as our eighth distribution partner just in the last year," says Willow Chief Marketing Officer, Sarah O'Leary.

Key Points: 
  • "Willow continues on a path of growth by adding The Motherly Shop as our eighth distribution partner just in the last year," says Willow Chief Marketing Officer, Sarah O'Leary.
  • Moms, and those shopping for new and expecting moms, can expect to find Willow's most coveted products at The Motherly Shop.
  • Founded in 2014, Willow forever changed the way women pump with the world's first quiet all-in-one, in-bra wearable breast pump.
  • Motherly partners with experts, influencers and users to deliver snackable, personalized content in a voice and presentation Millennial women can rely on and relate to.

Willow Biosciences Partners with Researchers at the University of Lethbridge and University of Calgary to Study Effects Of Non-Psychoactive Cannabinoids on Pain, Inflammation and Depression

Retrieved on: 
Thursday, October 8, 2020

To support the research, Willow will be providing four different, non-plant derived cannabinoids for use in the study, which is set to begin in the fourth quarter of 2020.

Key Points: 
  • To support the research, Willow will be providing four different, non-plant derived cannabinoids for use in the study, which is set to begin in the fourth quarter of 2020.
  • Keith Sharkey, professor and Christophe Altier, associate professor, in the Department of Physiology and Pharmacology at the University of Calgary's Cumming School of Medicine.
  • "Willow is excited to be supporting research on the effects of cannabinoids that could ultimately have an impact on human health" said Trevor Peters, Willow's Chief Executive Officer.
  • Mr. Peters notes, "Supporting this team allows Willow to give back to the community and impactfully support the development of medical advancements.

Willow Biosciences announces successful production of pure cannabigerol

Retrieved on: 
Monday, September 21, 2020

This highly productive strain and simplified downstream process should enable manufacturing in smaller, capital-light, GMP-compliant fermentation production facilities, at a fraction of the cost and environmental footprint of plant cultivation and extraction.

Key Points: 
  • This highly productive strain and simplified downstream process should enable manufacturing in smaller, capital-light, GMP-compliant fermentation production facilities, at a fraction of the cost and environmental footprint of plant cultivation and extraction.
  • "Achieving scalable production of pure CBG is a pivotal milestone for both Willow and our industry" said Trevor Peters, Willow's Chief Executive Officer.
  • Providing Willow's prospective partners with high purity samples from its pilot production run is the most significant hurdle before entering into commercial agreements.
  • Willow's current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications.

Willow Glen Real Estate Icons John & Keli Kost Return to Intero in the Willow Glen Office

Retrieved on: 
Thursday, June 4, 2020

He obtained his real estate license in 1996 and had the opportunity to learn the business from his father, RC Kost, more popularly known as The King of Willow Glen.

Key Points: 
  • He obtained his real estate license in 1996 and had the opportunity to learn the business from his father, RC Kost, more popularly known as The King of Willow Glen.
  • Before that, he was with the Intero Willow Glen Office from 2007-2015 and was the general sales manager at RE/MAX from 2006-2007.
  • In 2011, Keli moved back to San Jose and was working in the Intero Willow Glen Office.
  • Between John and Keli, they have nearly 40 years of real estate experience and also hold current real estate licenses in Hawaii and Idaho.